OpenAlex
PricingAboutJobs
Log inGet started
Work

Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial

HTML

Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Oncology
DOI: 10.1016/s1470-2045(11)70034-1
Authors: Jean-Pascal Machiels, Somasundaram Subramanian, Agnes Ruzsa, Gabor Repassy, Igor Lifirenko, Annika Flygare, Per Sørensen, Tina Nielsen, Steen Lisby, Paul MJ Clement
Institutions: Cliniques Universitaires Saint-Luc, Russian Cancer Research Center NN Blokhin, Semmelweis University, Kursk Regional Clinical Oncology Center, Genmab (Denmark), Universitair Ziekenhuis Leuven
Language: English

Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Keywords: epidermal growth factor receptor, head and neck squamous cell carcinoma, recurrent or metastatic cancer, platinum-refractory disease, best supportive care, methotrexate, overall survival, progression-free survival, monoclonal antibodies, treatment safety, rash, dose titration, performance status, treatment-related adverse events
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2140747142
FWCI: 25.95
Cites: 33
Cited by: 258
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms